You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Projects

Cytotoxic Commercial Manufacturing Facility

Dr. Reddy’s Laboratories, Visakhapatnam, Andhra Pradesh, India

Projects

Cytotoxic Commercial Manufacturing Facility

Dr. Reddy’s Laboratories, Visakhapatnam, Andhra Pradesh, India

The new CGMP facility included two dedicated areas, one for oral dosage and the other for parenteral products for international market distribution. Solid dosage capabilities included wet and dry granulation through compression, coating, and final packaging. Parenteral operations supported formulation and primary/secondary packaging. Various isolation technologies were assigned to provide for primary containment and facility elements provided transition area supporting secondary containment and CGMP zoning (FDA, EMEA, MHRA, WHO). Produced materials will be used for submission and commercial use with batch sizes ranging from 0.75kg to 60kg.

  • Cyto Block: 30,700sf
  • Anti-hormonal Block: 16,000sf
  • Utility Block: 9,200sf

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue